MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
6.23
+0.05 (0.81%)
Sep 19, 2024, 4:00 PM EDT - Market closed
MiMedx Group Market Cap
MiMedx Group has a market cap or net worth of $914.62 million as of September 19, 2024. Its market cap has increased by 5.17% in one year.
Market Cap
914.62M
Enterprise Value
864.83M
1-Year Change
5.17%
Ranking
Category
Stock Price
$6.23
Market Cap Chart
Since February 12, 2008, MiMedx Group's market cap has increased from $34.30M to $914.62M, an increase of 2,566.53%. That is a compound annual growth rate of 21.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 18, 2024 | 907.30M | -11.10% |
Dec 29, 2023 | 1.02B | 222.97% |
Dec 30, 2022 | 316.00M | -53.35% |
Dec 31, 2021 | 677.40M | -32.82% |
Dec 31, 2020 | 1.01B | 19.81% |
Dec 31, 2019 | 841.60M | 323.34% |
Dec 31, 2018 | 198.80M | -85.80% |
Dec 29, 2017 | 1.40B | 44.30% |
Dec 30, 2016 | 970.30M | -4.97% |
Dec 31, 2015 | 1.02B | -17.19% |
Dec 31, 2014 | 1.23B | 44.18% |
Dec 31, 2013 | 855.20M | 156.74% |
Dec 31, 2012 | 333.10M | 297.02% |
Dec 30, 2011 | 83.90M | -2.67% |
Dec 31, 2010 | 86.20M | 173.65% |
Dec 31, 2009 | 31.50M | -81.05% |
Dec 31, 2008 | 166.20M | 384.55% |
Feb 12, 2008 | 34.30M | - |
View and export this data all the way back to 2008.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Aurinia Pharmaceuticals | 1.02B |
Cullinan Therapeutics | 1.02B |
Nuvation Bio | 1.01B |
Applied Therapeutics | 952.08M |
Perspective Therapeutics | 933.54M |
Immunome | 918.63M |
Pediatrix Medical Group | 916.07M |
PetIQ | 912.64M |